Top Markets
Coin of the day
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
주식 순위 #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
주가
$0.28545656
시가총액
$4.50M
변동 (1일)
5.97%
변동 (1년)
0.00%
국가
FR
거래 Acticor Biotech SAS (ALACT)

카테고리

Acticor Biotech SAS (ALACT)의 주가 이력
최고 종가: $0.29 (2024-12-01 기준)

최저 종가: $7.56 (2021-11-01 기준)
Acticor Biotech SAS의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2024 -90.82%
2023 -58.62%
2022 31.92%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$36.74 -53.49%
DK
$451.49 -11.91%
US
$737.00 9.61%
US
$297.72 51.37%
BE
$94.95 -40.77%
AU